Pharsight

Xeris patents expiration

1. Gvoke Hypopen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649364 XERIS Methods for producing stable therapeutic formulations in aprotic polar solvents
Apr, 2036

(12 years from now)

US11590205 XERIS Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
Apr, 2036

(12 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Sep 10, 2022

Drugs and Companies using GLUCAGON ingredient

Market Authorisation Date: 10 September, 2019

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

GVOKE HYPOPEN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic